CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Flexitouch +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00383500
NCT00383500N/ACompleted
CompareCT.gov

To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

Stanford University·interventional·Posted Oct 3, 2006·Updated Mar 30, 2017

In Brief

A clinical study evaluating Flexitouch and Class 1 compression garment for Lymphedema and Breast Cancer. Completed, enrolled 75 participants across 1 site.

Detailed Summary

To compare the effectiveness of usual treatments for lymphedema \[massage and elastic compression sleeve, instituted at-risk and before the development of swelling (lymphedema)\], compared to the use of a newly-marketed device, the Flexitouch, which electronically simulates the effect of massage upon lymph flow.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema, Breast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 3, 2006
Enrollment StartMay 1, 2005
Primary CompletionJul 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 19.7 years ago

Interventions

Flexitouchdevice

A standard of care intermittent pneumatic compression device (aka, lymphedema pump)

Class 1 compression garmentdevice

Manual lymphatic drainage therapy to provide lymphatic massage, using a Class 1 compression garment supporting the arm during heavy exercise or where the risk of trauma maybe increased (ie, flight, elevation, etc).